Related references
Note: Only part of the references are listed.The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF
Hiroko Shibata et al.
BIOMATERIALS (2009)
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-α in murine hepatitis models
Hiroko Shibata et al.
CYTOKINE (2008)
Developing therapeutic proteins by engineering ligand-receptor interactions
Douglas S. Jones et al.
TRENDS IN BIOTECHNOLOGY (2008)
Targeting TNF-alpha receptors for neurotherapeutics
Wayne Chadwick et al.
TRENDS IN NEUROSCIENCES (2008)
Creation and x-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-α antagonist
Hiroko Shibata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tumor necrosis factor receptor pre-ligand assembly domain is an important therapeutic target in inflammatory arthritis
Guo-Min Deng
BIODRUGS (2007)
Infliximab neutralizes the suppressive effect of TNF-α on expression of extracellular-superoxide dismutase in vitro
Tetsuo Adachi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: Guidelines for clinical approach
Debbie M. Nathan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors
GM Deng et al.
NATURE MEDICINE (2005)
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report
JJ Gómez-Reino et al.
ARTHRITIS AND RHEUMATISM (2003)
Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration
SL Brown et al.
ARTHRITIS AND RHEUMATISM (2002)
TNF receptor subtype signalling: Differences and cellular consequences
DJ MacEwan
CELLULAR SIGNALLING (2002)
Drug-induced systemic lupus erythematosus associated with etanercept therapy
N Shakoor et al.
LANCET (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function
FKM Chan
ANNALS OF THE RHEUMATIC DISEASES (2000)
Signaling by the TNF receptor superfamily and T cell homeostasis
FKM Chan et al.
IMMUNITY (2000)
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
FKM Chan et al.
SCIENCE (2000)
Share Paper
